Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes

Abstract

To the Editor: We read with great interest the report by Cooper et al. [1] on unblinded treatment for left-ventricular hypertrophy in type 2 diabetes patients using triethylenetetramine for chelation of copper vs placebo. The results are very promising and certainly merit independent confirmation in larger double-blind, placebo-controlled trials. The… (More)
DOI: 10.1007/s00125-009-1495-4

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics